Trials / Completed
CompletedNCT03003247
Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris
A Phase 2, Multi-Center, Randomized, Double-Blind, Vehicle- Controlled, Parallel-Group, Clinical Study Comparing the Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 364 (actual)
- Sponsor
- Bausch Health Americas, Inc. · Industry
- Sex
- All
- Age
- 9 Years
- Healthy volunteers
- Accepted
Summary
Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris
Detailed description
A Phase 2, Multi-Center, Randomized, Double-Blind, Vehicle- Controlled, Parallel-Group, Clinical Study Comparing the Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IDP-120 Gel | IDP-120 Gel is a combination product |
| DRUG | IDP 120 Component A Gel | Monad of Component A |
| DRUG | IDP 120 Component B Gel | Monad of Component B |
| DRUG | IDP 120 Vehicle Gel | Vehicle |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2016-08-31
- Completion
- 2016-09-30
- First posted
- 2016-12-26
- Last updated
- 2017-12-18
Locations
24 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT03003247. Inclusion in this directory is not an endorsement.